A Real-World Perspective of Patients With Episodic Migraine or Chronic Migraine Prescribed AJOVY in the United States

被引：0
|
作者：
Cohen, J. M. [1 ]
Pandya, S. [2 ]
Krasenbaum, L. J. [3 ]
Thompson, S. F. [3 ]
Chen, C. [2 ]
Tangirala, K. [3 ]
机构：
[1] Teva Branded Pharmaceut Prod R&D Inc, Frazer, PA USA
[2] STATinMED Res, Ann Arbor, MI USA
[3] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
来源：
HEADACHE | 2020年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [1] A Real-World Perspective on the Characteristics of Migraine Patients Prescribed Ajovy, Emgality, or Aimovig in the United States
    Cohen, Joshua M.
    Pandya, Shivani
    Krasenbaum, Lynda J.
    Thompson, Stephen F.
    Chen, Chien-Cheng
    Tangirala, Krishna
    [J]. ANNALS OF NEUROLOGY, 2020, 88 : S156 - S157
  • [2] Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
    Taoufik Alsaadi
    Suzan Noori
    Razmig Varakian
    Saly Youssef
    AbuBaker Almadani
    [J]. BMC Neurology, 22
  • [3] Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
    Alsaadi, Taoufik
    Noori, Suzan
    Varakian, Razmig
    Youssef, Saly
    Almadani, AbuBaker
    [J]. BMC NEUROLOGY, 2022, 22 (01)
  • [4] Real-world Reductions in Migraine and Headache Days for Patients With Chronic and Episodic Migraine Initiating Fremanezumab in the US
    Cohen, Joshua M.
    Thompson, Stephen
    Patterson-Lomba, Oscar
    Driessen, Maurice
    Seminerio, Michael
    Carr, Karen
    Mu, Fan
    [J]. NEUROLOGY, 2021, 96 (15)
  • [5] Clinical treatment of chronic and episodic migraine with onabotulinumtoxinA in a real-world setting
    Velasco-Juanes F.
    Gómez-Esteban J.C.
    Fernández-Valle T.
    Matute-Nieves A.
    Almeida-Velasco J.
    Lloret-Villas M.I.
    Ugarriza-Serrano I.
    [J]. Drugs & Therapy Perspectives, 2018, 34 (7) : 335 - 343
  • [6] Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
    Gladstone, Jonathan
    Chhibber, Sameer
    Minhas, Jagdeep
    Neish, Calum S.
    Power, G. Sarah
    Lan, Zhiyi
    Rochdi, Driss
    Lanthier-Martel, Jessica
    Bastien, Natacha
    [J]. HEADACHE, 2022, 62 (01): : 78 - 88
  • [7] PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine
    Ashina, Messoud
    Amin, Faisal Mohammad
    Kokturk, Pinar
    Cohen, Joshua M.
    Konings, Martijn
    Tassorelli, Cristina
    Lyras, Leonidas
    Mitsikostas, Dimos-Dimitrios
    [J]. PAIN MANAGEMENT, 2021, 11 (06) : 647 - 654
  • [8] A retrospective real world evaluation of Fremanezumab (Ajovy) in the management of refractory chronic migraine
    Ghadiri-Sani, Mona
    Broadhurst, Sarah
    Perry, Loouise
    Stockley, Angela M.
    [J]. CEPHALALGIA, 2022, 42 (1_SUPPL) : 70 - 70
  • [9] Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
    Driessen, Maurice T.
    Cohen, Joshua M.
    Thompson, Stephen F.
    Patterson-Lomba, Oscar
    Seminerio, Michael J.
    Carr, Karen
    Totev, Todor, I
    Sun, Rochelle
    Yim, Erica
    Mu, Fan
    Ayyagari, Rajeev
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [10] Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
    Maurice T. Driessen
    Joshua M. Cohen
    Stephen F. Thompson
    Oscar Patterson-Lomba
    Michael J. Seminerio
    Karen Carr
    Todor I. Totev
    Rochelle Sun
    Erica Yim
    Fan Mu
    Rajeev Ayyagari
    [J]. The Journal of Headache and Pain, 2022, 23
12345